1Zouboulis CC. Isotretinoin revisited pluripotent effects on humansebaceous gland cells [J]. J Invest Dermatol, 2006, 126 (10):2154-2156.
2On SC, Zeichner J. Isotretinoin updates [J]. Dermatol Ther,2013,26⑶:377-389.
3Nelson AM, Gilliland KL, Cong Z, et al. 13-cis retinoic acidinduces apoptosis and cell cycle arrest in human SEB-1 sebo-cytes[J]. J Invest Dermatol, 2006, 126(10): 2178-2189.
4Tsukada M,Schroder M,Roos TC, et al. 13-cis retinoic acidexerts its specific activity on human sebocytes through selectiveintracellular isomerization to all -trans retinoic acid and bindingto retinoid acid receptors [J]. J Invest Dermatol, 2000, 115(2):321-327.
5Karlsson T, Vahlquist A, Kedishvili N, et al. 13 -cis-retinoicacid competitively inhibits 3 alpha -hydroxysteroid oxidationbyretinol dehydrogenase RoDH-4: a mechanim for its anti-an-drogenic effects in sebaceous glands. [J]. Biochem Biophys ResCommun, 2003, 303(1): 273-278.
6Ganceviciene R, Zouboulis CC. Isotretinoin: state of the arttreatment for acne vulgaris [J]. J Dtsch Dermatol Ges, 2010,8Suppl 1: S47-S59.
7Karadag AS, Ertugrul DT, Bilgili SG, et al. Immunoregulatoryeffects of isotretinoin in patients with acne [J]. Br J Dermatol,2012, 167(2): 433-435.
